COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-1483

First 1483 Last

Share
Profile

Follow
logco

23,002 Posts.

69

26/04/21

13:16

Post #: 52723121
Share
Originally posted by kacy: ↑

"While some other studies did appear to show benefits of ivermectin, many did not. These were summarised by the National Institutes of Health, showing severe limitations arising from small sample sizes and problems with study design."

If you read the reports mentioned at that link, most trials show positive results results with Invemectin. e.g.:

Number of Participants:
IVM plus DOX plus standard therapy (n = 70) and standard therapy alone (n = 70)
Participant Characteristics:
Median age was 50 years in IVM arm and 47 years in standard therapy arm.
50% of patients were male in IVM arm and 53% were male in standard therapy arm.
In IVM arm, 48 patients had mild or moderate COVID-19, 11 had severe COVID-19, and 11 had critical COVID-19.
In standard therapy arm, 48 patients had mild or moderate COVID-19, 22 had severe COVID-19, and no patients had critical COVID-19.
Outcomes:
Mean recovery time in IVM arm was 10.1 days (SD 5.3 days) vs. 17.9 days (SD 6.8 days) for standard therapy arm (P < 0.0001). This result was only significant for those with mild to moderate disease.
Disease progression occurred in 3 of 70 patients (4.3%) in IVM arm and 7 of 70 (10.0%) in standard therapy arm (P = 0.19)
2 of 70 patients (2.85%) in IVM arm and 6 of 70 (8.57%) in standard therapy arm died (P = 0.14)

Unfortunately, the WHO continues to refuse to recommend Invermectin for covid. So you wont get it from your doctor or the hospital if you catch covid, you can only get it online, eg ebay. That's a pitty because it is possible the new mutant viruses breeding in India will be resistant to all the vaccines and Invermectin might be the only hope for many.

https://www.covid19treatmentguidelines.nih.gov/tables/table-2c/

Expand

This from the maker of invermectin.
KENILWORTH, N.J., Feb. 4, 2021 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today affirmed its position regarding use of ivermectin during the COVID-19 pandemic. Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to-date, our analysis has identified:
No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;
A concerning lack of safety data in the majority of studies.
We do not believe that the data available support the safety and efficacy of ivermectin beyond the doses and populations indicated in the regulatory agency-approved prescribing information.
1 Upvote

Reply